Alopecia areata: An update

Indian Journal of Dermatology, Venereology and Leprology

Volumn 79, Issue 5, 2013, Pages 563-575

  Seetharam, Kolalapudi Anjaneyulu ^a  

^a Katuri Medical College & Hospital   (India)

Author keywords

Alopecia areata; camouflage; etiopathogenesis; intralesional corticosteroids; treatment

Indexed keywords

ACRYLAMIDE; AZATHIOPRINE; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BEXAROTENE; CAPSAICIN; CLOBETASOL; CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; DITHRANOL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUOCINOLONE ACETONIDE; HALCINONIDE; INTERCELLULAR ADHESION MOLECULE 1; METHOTREXATE; METHYLPREDNISOLONE; MINOXIDIL; PREDNISOLONE; PROSTAGLANDIN DERIVATIVE; SALAZOSULFAPYRIDINE; STEROID; TRIAMCINOLONE ACETONIDE;

ACUTE AND DIFFUSE TOTAL ALOPECIA; ADDISON DISEASE; AGE DISTRIBUTION; ALLELE; ALOPECIA AREATA; ALOPECIA TOTALIS; ALOPECIA UNIVERSALIS; ANAPHYLAXIS; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CATARACT; CELIAC DISEASE; CHROMOSOME 10; CHROMOSOME 16; CHROMOSOME 18; CHROMOSOME 6P; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DERMATITIS; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DOWN SYNDROME; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; EPILUMINESCENCE MICROSCOPY; FAMILIAL DISEASE; FAMILY HISTORY; FOLLICULITIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HISTOPATHOLOGY; HUMAN; HYPOPIGMENTATION; IMMUNOTHERAPY; INTRAOCULAR PRESSURE; IRON DEFICIENCY; LINEAR ALOPECIA; LONG TERM EXPOSURE; LYMPHADENOPATHY; MALE TYPE ALOPECIA; MONOZYGOTIC TWINS; MULTIFACTORIAL INHERITANCE; NAIL; OPHIASIS; PAPER INDUSTRY; PATCHY ALOPECIA; PATHOGENESIS; PATIENT COUNSELING; PERINEVOID ALOPECIA; PHOTOTHERAPY; PRURITUS; PSORIASIS; PUNCH BIOPSY; PUVA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETICULAR ALOPECIA; REVIEW; SALT SCORE; SCALP PRURITUS; SCORING SYSTEM; SECONDARY SYPHILIS; SIDE EFFECT; SINGLE DRUG DOSE; SISAIPHO; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN COLOR; SKIN IRRITATION; SKIN PAIN; SUBCUTANEOUS FAT; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC THERAPY; TELANGIECTASIA; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; VIRUS ETIOLOGY; VITILIGO;

ADRENAL CORTEX HORMONES; ALOPECIA AREATA; HUMANS; SCALP;

EID: 84884391255     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.116725     Document Type: Review

References (112)

1. McMichael AJ, Pearce DJ, Wasserman D, Camacho FT, Fleischer Jr AB, Feldman SR, et al. Alopecia in the United States: Outpatient utilization and common prescribing patterns. J Am Acad Dermatol 2007;57:S49-51
2. Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in Northern India. Int J Dermatol 1996;35:22-7
3. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995;70:628-33
4. Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern of alopecia areata in Singapore - A study of 219 Asians. Int J Dermatol 2002;41:748-53
5. Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol 2007;46:121-31
6. Al-Mutairi N, Eldin ON. Clinical profile and impact on quality of life: Seven years experience with patients of alopecia areata. Indian J Dermatol Venereol Leprol 2011;77:489-93
7. Bhat YJ, Manzoor S, Khan AR, Qayoom S. Trace element levels in alopecia areata. Indian J Dermatol Venereol Leprol 2009;75:29-31
8. Muller SA, Winkelmann RK. Alopecia areata - An evaluation of 736 patients. Arch Dermatol 1963;88:290-7
9. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part I. Clinical picture, histopathology,and pathogenesis. J Am Acad Dermatol 2010;62:177-88
10. Tosti A, La Placa M, Placucci F, Gentilomi G, Venturoli S, Zerbini M, et al. No correlation between CMV and alopecia areata. J Invest Dermatol 1996;107:443
11. Rodriguez TA, Fernandes KE, Dresser KL, Duvic M. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol 2010;62:525-7
12. Martinez-Mir A, Zlotogorski A, Gordon D, Petukhova L, Mo J, Gilliam TC, et al. Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet 2007;80:316-28
13. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010;466:113-7
14. Barahmani N, Andrade M, Slusser JP, Wei Q, Hordinsky M, Price VH, et al. Human leukocyte antigen class II alleles are associated with risk of alopecia areata. J Invest Dermatol 2008;128:240-3
15. Petukhova L, Cabral RM, Mackay-Wiggan J, Clynes R, Christiano AM. The genetics of alopecia areata: What's new and how will it help our patients? Dermatol Ther 2011;24:326-36
16. Wang E, McElwee KJ. Etiopathogenesis of alopecia areata: Why do our patients get it? Dermatol Ther 2011;24:337-47
17. Sundberg JP, Silva KA, Zhang W, Sundberg, BA, Edwards K, King LE, et al. Recombinant human hepatitis B vaccine initiating alopecia areata: Testing the hypothesis using the C3H/HeJ mouse model. Vet Dermatol 2009;20:99-104
18. Gupta MA, Gupta AK, Watteel GN. Stress and alopecia areata: A psychodermatologic study. Acta Derm Venereol 1997:77:296-8
19. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006;54:824-44
20. McElwee KJ, Sinclair R. Hair physiology and its disorders. Drug Discov Today Dis Mech 2008;5:e163-71
21. Offidani A, Amerio P, Bernardini ML, Feliciani C, Bossi G. Role of cytomegalovirus replication in alopecia areata pathogenesis. J Cutan Med Surg 2000;4:63-5
22. Bruske K, Salfeld K. Zinc and its status in some dermatological diseases: A statistical assessment. Z Hautkr 1987;62:125-31
23. Roselino AM, Almeida AM, Hippolito MA, Cerqueira BC, Maffei CM, Mfnezes JB, et al. Clinical-epidemiologic study of alopecia areata. Int J Dermatol 1996;35:181-4
24. Barahmani N, Schabath MB, Duvic M. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 2009;61:581-91
25. Xiao FL, Yang S, Liu JB, He PP, Yang J, Cui Y, et al. The epidemiology of childhood alopecia areata in China: A study of 226 patients. Pediatr Dermatol 2006;23:13-8
26. Leung MC, Sutton CW, Fenton DA, Tobin DJ. Trichohyalin a potential major autoantigen in human alopeciaareata. J Proteome Res 2010;9:5153-63
27. Kang H, Wu WY, Lo BK, Yu M, Leung G, Shapiro J, et al. Hair follicles from alopecia areata patients exhibit alterations in immune privilege associated gene expression in advance of hair loss. J Invest Dermatol 2010;130:2677-80
28. Gilhar A. Collapse of immune privilege in alopecia areata: Coincidental or substantial? J Invest Dermatol 2010;130:2535-7
29. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-66
30. Finner AM. Alopecia areata: Clinical presentation, diagnosis, and unusual cases. Dermatol Ther 2011;24:348-54
31. Sato-Kawamura M, Aiba S, Tagami H. Acute diffuse and total alopecia of the female scalp. A new subtype of diffuse alopecia areata that has a favorable prognosis. Dermatology 2002;205:367-73
32. Lew BL, Shin MK, Sim WY. Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis. J Am Acad Dermatol 2009;60:85-93
33. Yesudian P, Thambiah AS. Perinevoid alopecia. An unusual variety of alopecia areata. Arch Dermatol 1976;112:1432-4
34. Ikeda T. A new classification of alopecia areata. Dermatologica 1965;131:421-45
35. Shuster S. 'Coudability': A new physical sign of alopecia areata. Br J Dermatol 1984;111:629
36. Messenger AG. Alopecia areata. Disorders of hair. Rook's text book of dermatology. 8th ed. In: Burns DA, Breathnach SM, Cox NH, Griffiths CE, editors. Oxford,UK: Blackwell publishing limited; 2010. p. 66.31-8
37. Ito T. Advances in the management of alopecia areata. J Dermatol 2012;39:11-7
38. Tosti A, Whiting D, Iorizzo M, Pazzaglia M, Misciali C, Vincenzi C, et al. The role of scalp dermoscopy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol 2008;59:64-7
39. Inui S, Nakajima T, Nakagawa K, Itami S. Clinical significance of dermoscopy in alopecia areata: Analysis of 300 cases. Int J Dermatol 2008;47:688-93
40. Mane M, Nath AK, Thappa DM. Utility of dermoscopy in alopecia areata. Indian J Dermatol 2011;56:407-11
41. Inui S, Nakajima T, Itami S. Coudability hairs: A revisited sign of alopecia areata assessed by trichoscopy. Clin Exp Dermatol 2010;35:361-5
42. SharmaVK, Dawn G, Muralidhar S, Kumar B. Nail changesin 1000 Indian patients with alopecia areata. J Eur Acad Dermatol Venereol 1998;10:189-91
43. Gandhi V, Baruah MC, Bhattacharaya SN. Nail changes in alopecia areata: Incidence and pattern. Indian J Dermatol Venereol Leprol 2003;69:114-5
44. Kasumagic-Halilovic E, Prohic A. Nail changes in alopecia areata: Frequency and clinical presentation. J Eur Acad Dermatol Venereol 2009;23:240-1
45. Dotz WI, Leiber CD, Wogt PJ. Leuconychia punctata and pitted nails in alopecia areata. Arch Dermatol 1985;121:1452-4
46. Hordinsky M, Ericson M. Autoimmunity: Alopecia areata. J Investig Dermatol Symp Proc 2004;9:73-8
47. Kasumagic-Halilovic E. Thyroid autoimmunity in patientswith alopecia areata. Acta Dermatovenerol Croat 2008;16:123-5
48. Thomas EA, Kadyan RS. Alopecia areata and autoimmunity: A clinical study. Indian J Dermatol 2008;53:70-4
49. Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: Associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006;20:1055-60
50. Wang SJ, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI. Increased risk for type I (insulin-dependent) diabetes in relatives of patients with alopecia areata (AA). Am J Med Genet 1994;51:234-9
51. Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, et al. Comorbidity profiles among patients with alopecia areata: The importance of onset age, a nationwide population-based study. J Am Acad Dermatol 2011;65:949-56
52. Dubois M, Baumstarck-Barrau K, Gaudy-Marqueste C, Richard MA, Loundou A, Auquier P, et al. Quality of life in alopecia areata: A study of 60 Cases. J Invest Dermatol 2010;130:2830-3
53. Pandhi D, Singal A, Gupta R, Das G. Ocular alterations in patients of alopecia areata. J Dermatol 2009;36:262-8
54. Dy LC, Whiting DA. Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?t Dermatol Thera 2011;24:369-7
55. Chaitra V, Rajalakshmi T, Kavdia R. Histopathologic profile of alopecia areata in Indian patients. Int J Trichol 2010;2:14-7
56. Whiting DA. Structural abnormalities of the hair shaft. J Am Acad Dermatol 1987;16:1-25
57. Gupta LK, Khare AK, Garg A, Mittal A. Congenital triangular alopecia: A close mimicker of alopecia areata. Int J Trichol 2011;3:40-1
58. Olsen EA. Investigative guidelines for alopecia areata. Dermatol Ther 2011;24:311-9
59. Bartels NG, Jahnke I, Patzelt A, Richter H, Lademann J, Blume-Peytavi U. Hair shaft abnormalities in alopecia areata evaluated by optical coherence tomography. Skin Res Technol 2011;17:201-5
60. Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, et al. National Alopecia Areata Foundation. Alopecia areata investigational assessment guidelines. Part II. National Alopecia Areata Foundatin. J Am Acad Dermatol 2004;51:440-7
61. Tosti A, Bellavista S, Iorizzo M. Alopecia areata: A long term follow-up study of 191 patients. J Am Acad Dermatol 2006;55:438-41
62. Delamere FM, Sladden MJ, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata (Review). Cochrane Database Syst Rev 2008;CD004413
63. Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 2003;49:96-8
64. AlKhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part II. Treatment. J Am Acad Dermatol 2010;62:191-202
65. Thappa DM, Vijayikumar M. Alopecia areata. Indian J Dermatol Venereol Leprol 2001;67:188
66. Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AB, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 2004;50:541-53
67. Fiedler VC, Wendrow A, Szpunar GJ, Metzler C, DeVillez RL. Treatment resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. Arch Dermatol 1990;126:756-9
68. Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2007;57:767-74
69. Mohan KH, Balachandran C, Shenoi SD, Rao R, Sripathi H, Prabhu S. Topical dinitrochlorobenzene (DNCB) for alopecia areata: Revisited. Indian J Dermatol Venereol Leprol 2008;74:401-2
70. Avgerinou G, Gregoriou S, Rigopoulos D, Stratigos A, Kalogeromitros D, Katsambas A. Alopecia Areata: Topical immunotherapy treatment with diphencyprone. J Eur Acad Dermatol Venereol 2008;22:320-3
71. Singh G, Lavanya MS. Topical immunotherapy in alopecia areata. Int J Trichol 2010;2:36-9
72. Muthuvel K. Practicality in using diphenyl cyclo propenone for alopecia areata. Int J Trichol 2011;3:96-7
73. Behrens-Williams SC, Leiter U, Schiener R, Weidmann M, Peter RU, Kerscher M. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata. J Am Acad Dermatol 2001;44:248-52
74. Sornakumar L, Sekar CS, Srinivas CR. Turban PUVASOL: An effective treatment in alopecia totalis. Int J Trichol 2010;2:106-7
75. Tosti A, Pazzaglia M, Voudouris S, Tosti G. Hypertrichosis of the eyelashes caused by bimatoprost. J Am Acad Dermatol 2004;51:S149-50
76. Coronel-Perez IM, Rodriguez-Rey EM, Camacho-Martinez FM. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. J Eur Acad Dermatol Venereol 2010;24:481-5
77. Vila TO, Camacho Martinez FM. Bimatoprost in the treatment of eyelash universalis alopecia areata. Int J Trichol 2010;2:86-8
78. Shapiro J, Price VH. Hair regrowth. Therapeutic agents. Dermatol Clin 1998;16:341-56
79. Sohn KC, Jang S, Choi DK, Lee YS, Yoon TJ, Jeon EK, et al. Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells. Biochem Biophys Res Commun 2007;356:810-5
80. Friedli A, Labarthe MP, Engelhardt E, Feldmann R, Salomon D, Saurat JH. Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients. J Am Acad Dermatol 1998;39:597-602
81. Kar BR, Handa S, Dogra S, Kumar B. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 2005;52:287-90
82. Kurosawa M, Nakagawa S, Mizuashi M, Sasaki Y, Kawa- mura M, Saito M, et al. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 2006;212:361-5
83. Thappa DM, Vijaikumar S. Intravenous dexamethasone pulse therapy for extensive alopecia areata. Indian J Dermatol 1999;44:187-90
84. Sharma VK. Pulsed administration of corticosteroids in the treatment of alopecia areata. Int J Dermatol 1996;35:133-6
85. Pasricha JS, Kumrah L. Alopecia totalis treated with oral minipulse (OMP) therapy with betamethasone. Indian J Dermatol Venereol Leprol 1996;62:106-9
86. Khaitan BK, Mittal R, Verma KK. Extensive alopecia areata treated with betamethasone oral mini-pulse therapy: An open uncontrolled study. Indian J Dermatol Venereol Leprol 2004;70:350-3
87. Sharma VK, Gupta S. Twice weekly dexamethasone oral pulse in the treatment of extensive alopecia areata. J Dermatol 1999;26:562-5
88. Rashidi T, Mahd AA. Treatment of persistent alopecia areata with sulfasalazine. Int J Dermatol 2008;47:850-2
89. Aghaei S. An uncontrolled, open label study of sulfasalazine in severe alopecia areata. Indian J Dermatol Venereol Leprol 2008;74:611-3
90. Mohamed Z, Bhouri A, Jallouli A, Fazaa B, Kamoun MR, Mokhtar I, et al. Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen. J Eur Acad Dermatol Venereol 2005;19:552-5
91. Ferrando J, Grimalt R. Partial response of severe alopecia areata to cyclosporine A. Dermatology 1999;199:67-9
92. Chartaux E, Joly P. Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis. (Article in French). Ann Dermatol Venereol 2010;137:507-13
93. Farshi S, Mansouri P, Safar F, Khiabanloo SR. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study. Int J Dermatol 2010;49:1188-93
94. Ehsani A, Toosi S, Seirafi H, Akhyani M, Hosseini M, Azadi R, et al. Capsaicin vs. Clobetasol for the treatment of localized alopecia areata. J Eur Acad Dermatol Venereol 2009;23:1451-3
95. Talpur R, Vu J, Bassett R, Stevens V, Duvic M. Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata. J Am Acad Dermatol 2009;61:592. e1-9
96. Draelos ZD. Camouflage technique for alopecia areata: What is a patient to do? Dermatol Ther 2011;24:305-10
97. Price VH,Willey A, Chen BK. Topical tacrolimus in alopecia areata. J Am Acad Dermatol 2005;52:138-9
98. Rigopoulos D, Gregoriou S, Korfitis C, Gintzou C, Vergou T, Katrinaki A, et al. Lack of response of alopecia areata to pimecrolimus cream. Clin Exp Dermatol 2007;32:456-7
99. Otberg N. Systemic treatment for alopecia areata. Dermatol Ther 2011;24:320-5
100. Kirshen C, Kanigsberg N. Alopecia areata following adalimumab. J Cutan Med Surg 2009;13:48-50
101. Bayramgürler D, Demirsoy EO, Aktürk AS, Kiran R. Narrowband ultraviolet B phototherapy for alopecia areata. Photodermatol Photoimmunol Photomed 2011;27:325-7
102. Inui S, Nakajima T, Toda N, Itami S. Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata. J Dermatol 2010;37:888-93
103. Al-Mutairi N. 308-nm excimer laser for the treatment of alopecia areata. Dermatol Surg 2007;33:1483-7
104. Tzung TY, Chen CY, Tzung TY, Kao FJ, Chen WC. Infrared irradiation as an adjuvant therapy in recalcitrant alopecia areata. Dermatol Surg 2009;35:721-3
105. Fernandez-Guarino M, Harto A, Garcia-Morales I, Perez-Garcia B, Arrazola JM, Jaen P. Failure to treat alopecia areata with photodynamic therapy. Clin Exp Dermatol 2008;33:585-7
106. Shulaia T, Kiladze N, Babilashvili I.Mesotherapy in treatment of alopecia areata. J Exp Clin Med 2007;1:19-22
107. Duque-Estrada B, Vincenzi C, Misciali C, Tosti A. Alopecia secondary to mesotherapy. J Am Acad Dermatol 2009;61:707-9
108. Gilhar A, Pillar T, Etzioni A. Topical cyclosporin A in alopecia areata. Acta DermVenereol 1989;69:252-3
109. Hajheydari Z, Jamshidi M, Akbari J, Mohammadpour R. Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: A doubleblind randomized controlled study. Indian J Dermatol Venereol Leprol 2007;73:29-32
110. Yoo KH, Kim MN, Kim BJ, Kim CW. Treatment of alopecia areata with fractional photothermolysis laser. Int J Dermatol 2010;49:845-7
111. Alsantali A, Alopecia areata: A new treatment plan. Clin Cosmet Investig Dermatol 2011;4:107-15
112. Hordinsky MK. Treatment of alopecia areata:"What is new on the horizon?" Dermatol Ther 2011;24:364-8.